Pituitary adenylate-cyclase-activating polypeptide (PACAP): another novel target for treatment of primary headaches?

J Headache Pain. 2018 May 8;19(1):33. doi: 10.1186/s10194-018-0860-4.

Authors

Messoud Ashina¹, Paolo Martelletti^{2

3}

Affiliations

¹ Department of Neurology, Danish Headache Center, Rigshospitalet Glostrup, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. ashina@dadlnet.dk.
² Department of Clinical and Molecular Medicine, Sapienza University, Rome, Italy.
³ Regional Referral Headache Centre, Sant'Andrea Hospital, Rome, Italy.

No abstract available

Publication types

Editorial